Onward Medical N.V. (EBR:ONWD)

Market Cap	221.64M
Revenue (ttm)	2.72M
Net Income (ttm)	-38.65M
Shares Out	44.69M
EPS (ttm)	-0.78
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	106,228
Average Volume	123,565
Open	5.080
Previous Close	5.100
Day's Range	4.900 - 5.080
52-Week Range	3.500 - 7.240
Beta	0.95
RSI	45.58
Earnings Date	Sep 4, 2025

About Onward Medical

Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company engages in developing ARCEX, a technology to enhance hand strength and sensation for individuals with SCI; ARCIM, a spinal cord stimulation system designed to address blood pressure instability and other symptoms in people with SCI; ARCBCI, an implanted brain-computer interface to restore thought-driven movement. It operates in France, Germany, the Netherlands, the United Ki...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2014
• Employees: 103
• Stock Exchange: Euronext Brussels
• Ticker Symbol: ONWD

Financial Performance

In 2024, Onward Medical's revenue was 1.74 million, an increase of 226.88% compared to the previous year's 532,000. Losses were -35.73 million, -1.26% less than in 2023.